This topic contains a solution. Click here to go to the answer

Author Question: A supervisor can build trust by A) Communicating facts. B) Recognizing sensitive issues. C) ... (Read 26 times)

debasdf

  • Hero Member
  • *****
  • Posts: 570
A supervisor can build trust by
 
  A) Communicating facts.
  B) Recognizing sensitive issues.
  C) Maintaining authority.
  D) All of the above.
  E) A and B.

Question 2

Which of the following is not a goal in correspondence or presentations?
 
  A) Inform. B) Build trust. C) Conclude. D) Instruct.



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

makaylafy

  • Sr. Member
  • ****
  • Posts: 347
Answer to Question 1

E

Answer to Question 2

C




debasdf

  • Member
  • Posts: 570
Reply 2 on: Jun 23, 2018
Excellent


LegendaryAnswers

  • Member
  • Posts: 341
Reply 3 on: Yesterday
Wow, this really help

 

Did you know?

Blastomycosis is often misdiagnosed, resulting in tragic outcomes. It is caused by a fungus living in moist soil, in wooded areas of the United States and Canada. If inhaled, the fungus can cause mild breathing problems that may worsen and cause serious illness and even death.

Did you know?

Many of the drugs used by neuroscientists are derived from toxic plants and venomous animals (such as snakes, spiders, snails, and puffer fish).

Did you know?

Nearly 31 million adults in America have a total cholesterol level that is more than 240 mg per dL.

Did you know?

Though newer “smart” infusion pumps are increasingly becoming more sophisticated, they cannot prevent all programming and administration errors. Health care professionals that use smart infusion pumps must still practice the rights of medication administration and have other professionals double-check all high-risk infusions.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

For a complete list of videos, visit our video library